Gougerot Carteaud - Een Diepgaande Verkenning van Huidaandoeningen

Abstract

Confluent and reticulated papillomatosis (CRP) is an underdiagnosed skin condition of uncertain etiology. The antibacterial and most importantly the anti‐inflammatory mechanisms of some antibiotics seem to explain the effectiveness of these medications. Other measures such as reducing weight and treating an underlying endocrine disorder may be helpful.

Bacterial proliferation and endocrine factors may have synergistic contributions to the development of CRP. Treatment is therefore based on antibiotics but other measures such as reducing weight and screening for endocrine disorders may be useful.

References

1. Ferreira L. M., Diniz L. M., Ferreira C. J. M. Confluent and reticulated papillomatosis of Gougerot and Carteaud: report of three cases. Anais Brasileiros de Dermatologia. 2009, 84 (1):78–81. doi: 10.1590/s0365-05962009000100012. [PubMed] [CrossRef] [Google Scholar]

2. Jankowska-Konsur A., Maj J., Tupikowska M., Szepietowski J. C. Confluent brownish papules and plaques on the neck, upper chest and back: a quiz. Acta Dermato-Venereologica. 2013, 93 (4):493–495. doi: 10.2340/00015555-1504. [PubMed] [CrossRef] [Google Scholar]

3. Scheinfeld N. Confluent and reticulated papillomatosis: a review of the literature. American Journal of Clinical Dermatology. 2006, 7 (5):305–313. doi: 10.2165/00128071-200607050-00004. [PubMed] [CrossRef] [Google Scholar]

4. Pham-Ledard A., Ezzedine K., Couprie B., Begueret H., Boralevi F., Taieb A. Facial confluent and reticulate papillomatosis (Gougerot-Carteaud syndrome) or hyperkeratotic head and neck Malassezia dermatitis? Annales de Dermatologie et de Venereologie. 2010, 137 (6-7):451–454. doi: 10.1016/j.annder.2010.04.001. [PubMed] [CrossRef] [Google Scholar]

5. Hudacek K. D., Haque M. S., Hochberg A. L., Cusack C. A., Chung C. L. An unusual variant of confluent and reticulated papillomatosis masquerading as tinea versicolor. Archives of Dermatology. 2012, 148 (4):505–508. doi: 10.1001/archdermatol.2011.2812. [PubMed] [CrossRef] [Google Scholar]

6. Bowman P. H., Davis L. S. Confluent and reticulated papillomatosis: response to tazarotene. Journal of the American Academy of Dermatology. 2003, 48 (5):S80–S81. doi: 10.1067/mjd.2003.155. [PubMed] [CrossRef] [Google Scholar]

7. Davis M. D. P., Weenig R. H., Camilleri M. J. Confluent and reticulate papillomatosis (Gougerot-Carteaud syndrome): a minocycline-responsive dermatosis without evidence for yeast in pathogenesis. A study of 39 patients and a proposal of diagnostic criteria. British Journal of Dermatology. 2006, 154 (2):287–293. doi: 10.1111/j.1365-2133.2005.06955.x. [PubMed] [CrossRef] [Google Scholar]

Confluent and Reticulated Papillomatosis of Gougerot-Carteaud on Black Skin: Two Observations

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Confluent and reticulated papillomatosis of Goujerot-Carteaud is a rare and benign skin disease characterized by flat papules taking a reticulated appearance. It is a skin disease of unknown etiology and nosology that is always discussed. This disease preferentially involves the chest and interscapular regions. It is a condition probably underdiagnosed in black skin because it generally simulates a pigmented tinea versicolor. This pathology withstands antifungal treatment but has a particular sensitivity to cyclines thus constituting a distinguishing criterion, useful for diagnosis which should be evoked in front of these reticulated confluent papules.

Unusual Clinical Scenarios to Consider in Patient Management

Be careful to differentiate between widespread and acute onset acanthosis nigricans. which can be a paraneoplastic syndrome, especially when it does not respond to therapy directed at CARP.

Baalbaki, SA, Malak, JA, al-Khars, MA. “Confluent and reticulated papillomatosis. Treatment with etretinate”. Arch Dermatol. vol. 129. 1993. pp. 961-3. (This article describes the use of etretinate in CARP.)

Gonul, M, Cakmak, SK, Soylu, S, Kilic, A, Gul, U, Ergul, G. “Successful treatment of confluent and reticulated papillomatosis with topical mupirocin”. J Eur Acad Dermatol Venereol. vol. 22. 2008. pp. 1140-2. (Bacterial infection may be the cause of CARP mupirocin may be effective for this reason.)

Katayama, I, Yokozeki, H, Nishioka, K. “Oral minocycline improved keratosis follicularis squamosa (Dohi) and reticulated disorders: Bacterial factors are possibly involved in aberrant keratinization”. J Dermatol. vol. 21. 1994. pp. 604-8. (This article discusses the possible bacterial pathophysiology of CARP.)

Henning, JP, de Wit, RF. “Familial occurrence of confluent and reticulated papillomatosis”. Arch Dermatol. vol. 117. 1981. pp. 809-10. (A case of familial CARP.)

Kägi, MK, Trüeb, R, Wüthrich, B, Burg, G. “Confluent and reticulated papillomatosis associated with atopy. Successful treatment with topical urea and tretinoin”. Br J Dermatol. vol. 134. 1996. pp. 381-2. (This article discusses alternate therapies for CARP.)

Kurkcuoglu, N, Celebi, CR. “Confluent and reticulated papillomatosis: response to topical calcipotriol”. Dermatology. vol. 191. 1995. pp. 341-2. (Calcipotriol for CARP.)

Hirokawa, M, Matsumoto, M, Iizuka, H. “Confluent and reticulated papillomatosis: a case with concurrent acanthosis nigricans associated with obesity and insulin resistance”. Dermatology. vol. 188. 1994. pp. 148-51. (This article discusses the possible link between insulin resistance and CARP.)